0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Rapid detection of drug-resistant Mycobacterium tuberculosis by Modified MODS assay suitable for resource-poor settings

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Cross contamination and biosafety are concerns with the microscopic observation drug susceptibility assay. To address these issues, we modified the MODS technique in the current study.

          Methodology/Principal findings

          Two hundred and seventy-five samples were processed on LJ media and drug susceptibility was performed by the Indirect agar proportion method. A modified MODS test was done in tissue culture bottles. GenoType MTBDR plus assay was performed to detect the resistance and mutational pattern associated with the resistances. Sensitivity, specificity, positive predictive value, and negative predictive value for the detection of tuberculosis by modified MODS were 97.44%, 80.00%, 97.44%, and 80.00% respectively. The perfect agreement was seen between modified MODS and the Indirect agar proportion method for drug susceptibility testing of isoniazid (kappa = 0.923) and rifampicin (kappa = 1). The contamination rate, cost and TAT for modified MODS were less as compared to the solid media.

          In the case of MDR-TB isolates S531L (66.66%) was the most prevalent mutation in the rpoB gene followed by S315T2 mutation (58.33%) and T8C (41.66%) in katG and inhA gene respectively. In hetero-resistant strains, C-15T mutation (37.50%) was the most common followed by A-16G (12.50%) in the inhA gene. In INH mono-resistant strains only two mutations were observed i.e., S-315T1(50%) and C-15T (50%) in the katG and inhA genes respectively.

          Conclusions/Significance

          Modified MODS proved to be cost-effective and user-friendly, with minimal risk to the handler and no cross-contamination between samples were observed. Hence, it can be used in low-income countries for early detection of tuberculosis and its resistance.

          Author summary

          Tuberculosis is a major health problem, particularly in developing countries. Globally efforts are being made to control this disease. However, the emergence of multi-drug resistance (MDR) is a major threat to the tuberculosis control program. Moreover, the available methods for the detection of tuberculosis and susceptibility testing are time-consuming and labour-intensive. All these methods require pre-culture before drug susceptibility testing hence the turnaround time is prolonged. The microscopic observation drug susceptibility method is a liquid-based culture method which simultaneously detects tuberculosis and its susceptibility.

          Originally developed microscopic observation drug susceptibility assay is done in 24 well tissue culture plates, but problems of false positivity which likely represent cross-contamination from another positive specimen or positive controls plated on each MODS plate is the limitation of this assay. This method also poses the risk of exposure to infection to the person performing the assay. To overcome these issues, in the present study, we introduced modified MODS using screw-capped tissue culture bottles instead of tissue culture plates. The advantage of this modification is that samples and controls are processed in separate bottles which are screw-caped hence reducing chances of cross-contamination and risk of exposure to infection. The mutational pattern of drug-resistant strains is not known in this region. GenoType MTBDR plus assay was performed to detect the resistance and mutational pattern associated with the resistances.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

          Knowledge of the molecular genetic basis of resistance to antituberculous agents has advanced rapidly since we reviewed this topic 3 years ago. Virtually all isolates resistant to rifampin and related rifamycins have a mutation that alters the sequence of a 27-amino-acid region of the beta subunit of ribonucleic acid (RNA) polymerase. Resistance to isoniazid (INH) is more complex. Many resistant organisms have mutations in the katG gene encoding catalase-peroxidase that result in altered enzyme structure. These structural changes apparently result in decreased conversion of INH to a biologically active form. Some INH-resistant organisms also have mutations in the inhA locus or a recently characterized gene (kasA) encoding a beta-ketoacyl-acyl carrier protein synthase. Streptomycin resistance is due mainly to mutations in the 16S rRNA gene or the rpsL gene encoding ribosomal protein S12. Resistance to pyrazinamide in the great majority of organisms is caused by mutations in the gene (pncA) encoding pyrazinamidase that result in diminished enzyme activity. Ethambutol resistance in approximately 60% of organisms is due to amino acid replacements at position 306 of an arabinosyltransferase encoded by the embB gene. Amino acid changes in the A subunit of deoxyribonucleic acid gyrase cause fluoroquinolone resistance in most organisms. Kanamycin resistance is due to nucleotide substitutions in the rrs gene encoding 16S rRNA. Multidrug resistant strains arise by sequential accumulation of resistance mutations for individual drugs. Limited evidence exists indicating that some drug resistant strains with mutations that severely alter catalase-peroxidase activity are less virulent in animal models. A diverse array of strategies is available to assist in rapid detection of drug resistance-associated gene mutations. Although remarkable advances have been made, much remains to be learned about the molecular genetic basis of drug resistance in Mycobacterium tuberculosis. It is reasonable to believe that development of new therapeutics based on knowledge obtained from the study of the molecular mechanisms of resistance will occur.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.

            With an estimated 9.4 million new cases globally, tuberculosis (TB) continues to be a major public health concern. Eighty percent of all cases worldwide occur in 22 high-burden, mainly resource-poor settings. This devastating impact of tuberculosis on vulnerable populations is also driven by its deadly synergy with HIV. Therefore, building capacity and enhancing universal access to rapid and accurate laboratory diagnostics are necessary to control TB and HIV-TB coinfections in resource-limited countries. The present review describes several new and established methods as well as the issues and challenges associated with implementing quality tuberculosis laboratory services in such countries. Recently, the WHO has endorsed some of these novel methods, and they have been made available at discounted prices for procurement by the public health sector of high-burden countries. In addition, international and national laboratory partners and donors are currently evaluating other new diagnostics that will allow further and more rapid testing in point-of-care settings. While some techniques are simple, others have complex requirements, and therefore, it is important to carefully determine how to link these new tests and incorporate them within a country's national diagnostic algorithm. Finally, the successful implementation of these methods is dependent on key partnerships in the international laboratory community and ensuring that adequate quality assurance programs are inherent in each country's laboratory network.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: SupervisionRole: ValidationRole: Writing – original draftRole: Writing – review & editing
                Role: SupervisionRole: Writing – original draftRole: Writing – review & editing
                Role: InvestigationRole: ResourcesRole: Writing – original draft
                Role: Formal analysisRole: Writing – original draft
                Role: Writing – original draft
                Role: InvestigationRole: Resources
                Role: InvestigationRole: Writing – original draft
                Role: Formal analysisRole: Writing – original draft
                Role: Resources
                Role: Editor
                Journal
                PLoS Negl Trop Dis
                PLoS Negl Trop Dis
                plos
                PLOS Neglected Tropical Diseases
                Public Library of Science (San Francisco, CA USA )
                1935-2727
                1935-2735
                4 January 2024
                January 2024
                : 18
                : 1
                : e0011852
                Affiliations
                [1 ] Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
                [2 ] All India Institute of Medical Sciences, New Delhi, India
                [3 ] State TB Officer, Directorate of Health Services, Kashmir Province, Srinagar, Jammu and Kashmir, India
                NIAID-ICER, INDIA
                Author notes

                The authors have declared that no competing interests exist.

                Author information
                https://orcid.org/0000-0003-3705-9631
                Article
                PNTD-D-23-00253
                10.1371/journal.pntd.0011852
                10766176
                38175831
                db21feb2-037c-48b9-9d0a-442f38365783
                © 2024 Fomda et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 25 February 2023
                : 7 December 2023
                Page count
                Figures: 5, Tables: 3, Pages: 14
                Funding
                Funded by: funder-id http://dx.doi.org/10.13039/501100001411, Indian Council of Medical Research;
                Award ID: 5/8/5/29/2012/ECD-I
                Award Recipient :
                This work was supported by the Indian Council of Medical Research (ICMR) under the Grant No 5/8/5/29/2012/ECD-I to BAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Medicine and Health Sciences
                Medical Conditions
                Infectious Diseases
                Bacterial Diseases
                Tuberculosis
                Medicine and Health Sciences
                Medical Conditions
                Tropical Diseases
                Tuberculosis
                Biology and Life Sciences
                Microbiology
                Microbial Control
                Antimicrobial Resistance
                Antibiotic Resistance
                Medicine and Health Sciences
                Pharmacology
                Antimicrobial Resistance
                Antibiotic Resistance
                Biology and Life Sciences
                Organisms
                Bacteria
                Actinobacteria
                Mycobacterium Tuberculosis
                Biology and Life Sciences
                Genetics
                Mutation
                Research and Analysis Methods
                Biological Cultures
                Tissue Cultures
                Medicine and Health Sciences
                Pharmacology
                Drugs
                Isoniazid
                Medicine and Health Sciences
                Medical Conditions
                Infectious Diseases
                Bacterial Diseases
                Tuberculosis
                Extensively Drug-Resistant Tuberculosis
                Medicine and Health Sciences
                Medical Conditions
                Tropical Diseases
                Tuberculosis
                Extensively Drug-Resistant Tuberculosis
                Medicine and Health Sciences
                Diagnostic Medicine
                Tuberculosis Diagnosis and Management
                Custom metadata
                All relevant data are within the manuscript and its Supporting Information files.

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article